Share Name Share Symbol Market Type Share ISIN Share Description
The Mission Marketing Group LSE:TMMG London Ordinary Share GB00B11FD453 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 40.00p 39.00p 41.00p 40.00p 40.00p 40.00p 11,000 07:53:25
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Media 144.1 5.9 5.4 7.5 33.36

Mission Marketing Group Share Discussion Threads

Showing 1101 to 1125 of 1125 messages
Chat Pages: 45  44  43  42  41  40  39  38  37  36  35  34  Older
DateSubjectAuthorDiscuss
13/7/2017
10:30
xd today...
dr biotech
12/7/2017
14:30
Since we last covered TMMG in January 2017, it has delivered another solid set of results, materially increased its dividend and announced an acquisition. Is there yet more to excite investors?
investorschampion
11/5/2017
14:36
This is simply much too cheap on almost all measures IMO. OK in an absolutely ideal world you'd have a ptbv discount, but given the acquisitions and the nature of the business, they're always stuffed full of intangibles. This is still way cheaper than its peers and whilst the balance sheet isn’t as strong as you'd like, it is improving - and they are VERY cheap on earnings & expect growth this year. Understandably, the Long Term Incentive Plan is unpopular but the target price for the options at 75p is kind of "N/A" AFAIAC. However, a share price of around 65pps (with a corresponding P/E of around 8 and falling) looks much more reasonable IMO; at which the anticipated yield (currently 4.2%) would be 2.77%, so still not unreasonable and only marginally behind the sector average.
gingerplant
28/4/2017
16:31
Everything we know and don't understand in that report!
red_shed2000
28/4/2017
15:22
Edison update:- http://www.edisoninvestmentresearch.com/research/report/the-mission-marketing-group22/full/ Consensus estimate forecasts:- Y/E 31/12/17 Pbt £7.9m EPS 7.3p Div 1.65p Y/E 31/12/18 Pbt £8.9m EPS 8.3p Div 1.80p
jeff h
20/4/2017
14:36
maybe, but also provided a nice reminder for me to top up!
qs99
20/4/2017
14:18
Price movements here are often spikey and random. I'm happy it's up on this occasion but I won't read anything into it.
dr biotech
20/4/2017
13:28
decent volume IMO as well
qs99
20/4/2017
13:02
well I have bought a few just in case...gla
qs99
20/4/2017
12:58
interesting spike today, despite earlier sell in IC? I wonder whether this will as it languishes be a target? DYOR
qs99
31/3/2017
20:09
Headline about the figures hiding a multitude of sins. Seems to point to lack of organic growth ( or clarity about it) I've not read the whole article though.
dr biotech
31/3/2017
10:31
Why Markie?
cliffpeat
31/3/2017
10:04
Sell recommendation in the IC
markie7
30/3/2017
16:33
As has been the pattern for some years, up on the news then down for no apparent reason in the days after. Have to wonder if this will ever breakb45 let alone 50...
dr biotech
23/3/2017
10:15
Finncap; Once again, management has demonstrated its ability to deliver consistent growth. Our two-year forecast profile implies a further 20% growth in profitability accompanied by strong cash generation. However, the stock continues to sit at a significant discount to its peers, which on a current year EV/EBITDA basis is now 38%. We raise our target price to 66p following the introduction of a 2018 forecast, implying 57% upside, which would effectively halve the peer group discount.
davebowler
23/3/2017
08:39
No hidden surprises - as we all know these were telegraphed in the IMS. Optimisitic forward looking statement though. Long term hold for me too
dr biotech
23/3/2017
08:33
Well nice results and outlook again....still holding and waiting!
red_shed2000
22/2/2017
10:45
If they get the share price to 75p they are welcome to the shares!!!
red_shed2000
22/2/2017
09:59
In a thinly traded, lowly rated company such as this a decent buyback program might even be able to create the vesting conditions (over 75p for 15 days) :-)
cockerhoop
22/2/2017
09:59
The usual problem with these schemes if that if the target is too challenging then it can actually become de-motivational (if such a word exists), as some affected parties see it as 'income' lost.
pj 1
25/1/2017
09:14
Perhaps yesterday's low was the floor. Let's hope so anyway.
dr biotech
23/1/2017
17:13
I agree Waiting for it to settle
battlebus2
23/1/2017
17:07
top-up opportunity. IMHO.
mfhmfh
23/1/2017
17:04
And that article was written when the share price was 47p!!
red_shed2000
23/1/2017
16:41
http://www.edisoninvestmentresearch.com/research/report/the-mission-marketing-group704438/preview#js Implies that they will miss their targets by a small amount. But also says undervalued compared to peers - its been like that for years. Perhaps it stems back to their near death experience some years ago.
dr biotech
Chat Pages: 45  44  43  42  41  40  39  38  37  36  35  34  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20170720 14:41:09